Form 4 for IDXX Idexx Laboratories
Accepted 2022-08-08 00:00:00 ET · period of report 2022-08-05 · accession 0001567619-22-015174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-08 | 2022-08-05 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | $0.00 | +192 | 28.4K | +0.7% | $0 |
| D | 2022-08-08 | 2022-08-05 | IDXX | MCKEON BRIAN P | CFO, Executive VP | F - Tax | $407.78 | -90 | 28.3K | -0.3% | -$36.7K |
| D | 2022-08-08 | 2022-08-05 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | — | -192 | 4,593 | -4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | M | A | 192 | $0.00 | 28,365.64 | D | — | — | (F1) Includes a total of 20 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022 and June 30, 2022. |
| 2 | Common | Common Stock | 2022-08-05 | F | D | 90 | $407.78 | 28,275.64 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-08-05 | M | D | 192 | — | 4,593 | D | — · — to — | 192 Common Stock | (F3) Not applicable. (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. |